These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 18449113)
1. Cardiovascular diseases in dental practice. Practical considerations. Margaix Muñoz M; Jiménez Soriano Y; Poveda Roda R; Sarrión G Med Oral Patol Oral Cir Bucal; 2008 May; 13(5):E296-302. PubMed ID: 18449113 [TBL] [Abstract][Full Text] [Related]
2. Optimal medical treatment of cardiovascular risk factors: can we prevent the development of heart failure? Alba AC; Delgado DH Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):147-57. PubMed ID: 19210211 [TBL] [Abstract][Full Text] [Related]
3. The systemic management of cardiovascular risk patients in dentistry. Matsuura H Anesth Pain Control Dent; 1993; 2(1):49-61. PubMed ID: 8329905 [TBL] [Abstract][Full Text] [Related]
4. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure. Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711 [TBL] [Abstract][Full Text] [Related]
5. Recent trends in coronary heart disease epidemiology in India. Gupta R Indian Heart J; 2008; 60(2 Suppl B):B4-18. PubMed ID: 19359764 [TBL] [Abstract][Full Text] [Related]
6. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment]. Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737 [TBL] [Abstract][Full Text] [Related]
7. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38. Wiviott SD; Braunwald E; Angiolillo DJ; Meisel S; Dalby AJ; Verheugt FW; Goodman SG; Corbalan R; Purdy DA; Murphy SA; McCabe CH; Antman EM; Circulation; 2008 Oct; 118(16):1626-36. PubMed ID: 18757948 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular risk and cardiometabolic protection: role of glitazones. Petrazzi L; Grassi D; Polidoro L; D'Aurelio A; Croce G; Properzi G; Tiberti S; Desideri G; Ferri C J Nephrol; 2008; 21(6):826-35. PubMed ID: 19034866 [TBL] [Abstract][Full Text] [Related]
9. Dental management of the patient with ischemic heart disease: an update. Silvestre FJ; Miralles-Jorda L; Tamarit C; Gascon R Med Oral; 2002; 7(3):222-30. PubMed ID: 11984504 [TBL] [Abstract][Full Text] [Related]
10. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Goto S; Bhatt DL; Röther J; Alberts M; Hill MD; Ikeda Y; Uchiyama S; D'Agostino R; Ohman EM; Liau CS; Hirsch AT; Mas JL; Wilson PW; Corbalán R; Aichner F; Steg PG; Am Heart J; 2008 Nov; 156(5):855-63, 863.e2. PubMed ID: 19061698 [TBL] [Abstract][Full Text] [Related]
11. [Dental management of patients with cardiovascular disease]. Migliau G Minerva Stomatol; 2002; 51(1-2):49-63. PubMed ID: 11845121 [TBL] [Abstract][Full Text] [Related]
12. Risk stratification and dental management of the patient with cardiovascular diseases. Part I: Etiology, epidemiology, and principles of medical management. Steinhauer T; Bsoul SA; Terezhalmy GT Quintessence Int; 2005 Feb; 36(2):119-37. PubMed ID: 15732548 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular ischemic event rates in outpatients with symptomatic atherothrombosis or risk factors in the united states: insights from the REACH Registry. Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Steg PG; Cannon CP; Brennan DM; Bhatt DL; Crit Pathw Cardiol; 2009 Jun; 8(2):91-7. PubMed ID: 19417637 [TBL] [Abstract][Full Text] [Related]
15. [Diabetes and ischemic heart disease: specific treatment]. Raddino R; Bonadei I; Teli M; Robba D; Caretta G; Madureri A; Zanini G; Pedrinazzi C; Vizzardi E; Cas LD G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):52S-55S. PubMed ID: 19195307 [TBL] [Abstract][Full Text] [Related]
16. Impaired renal function in acute myocardial infarction. Lekston A; Kurek A; Tynior B Cardiol J; 2009; 16(5):400-6. PubMed ID: 19753517 [TBL] [Abstract][Full Text] [Related]
17. [Anemia and myocardial ischemia: relationships and interferences]. Bellotto F; Cati A Recenti Prog Med; 2006 Mar; 97(3):153-64. PubMed ID: 16700423 [TBL] [Abstract][Full Text] [Related]
18. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice. Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492 [TBL] [Abstract][Full Text] [Related]
19. The case for chronic kidney disease, diabetes mellitus, and myocardial infarction being equivalent risk factors for cardiovascular mortality in patients older than 65 years. Rashidi A; Sehgal AR; Rahman M; O'Connor AS Am J Cardiol; 2008 Dec; 102(12):1668-73. PubMed ID: 19064021 [TBL] [Abstract][Full Text] [Related]
20. Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients. Costanzo P; Perrone-Filardi P; Petretta M; Marciano C; Vassallo E; Gargiulo P; Paolillo S; Petretta A; Chiariello M J Hypertens; 2009 Jun; 27(6):1136-51. PubMed ID: 19451836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]